Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

High-Performance Liquid Chromatography as a Novel Method for the Determination of α-Defensins in Synovial Fluid for Diagnosis of Orthopedic Infections

P. Melicherčík, E. Klapková, K. Kotaška, D. Jahoda, I. Landor, V. Čeřovský,

. 2020 ; 10 (1) : . [pub] 20200109

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc20005375

Grant support
16-27726A Ministerstvo Zdravotnictví Ceské Republiky
RVO 61388963 Ústav Organické Chemie a Biochemie, Akademie Věd České Republiky
9777 and 6010 Motol University Hospital
NV16-27726A MZ0 CEP Register

The α-defensins (AD) present in synovial fluid have been regarded as constituting the most accurate periprosthetic joint infection (PJI) biomarker. The methods most commonly used for estimating AD as a biomarker are the qualitative Synovasure® PJI tests, based on the technique of lateral flow, and quantitative enzyme-linked immunosorbent assay (ELISA). Here, we propose a novel test based on detecting α-defensins in synovial fluid by high-performance liquid chromatography (HPLC). Synovial fluid was collected from 157 patients diagnosed with PJI, infectious arthritis (IA), arthrosis, reactive arthritis, and rheumatoid arthritis. AD concentrations in the fluid were determined by HPLC, and these same samples were used for additional diagnostic analyses. The results were statistically processed to calculate cutoff concentrations for PJI and IA. HPLC testing showed a sensitivity of 94% and a specificity of 92% for diagnosis of PJI, and a sensitivity of 97% and a specificity of 87% for diagnosis of IA. Using HPLC, we detected in synovial fluid a combination of three α-defensins: human neutrophil peptides HNP1, HNP2, and HNP3. All measured AD concentration values shown in this work refer to the sum of these three individual concentrations. Our study shows that the HPLC method meets the conditions for measuring precise concentrations of the sum of AD and can be recommended as part of a diagnostic array for PJI and IA diagnostics. By this method, we have verified that higher levels of AD in synovial fluid can also be seen in rheumatoid illnesses, crystal arthropathies, and reactive arthritis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005375
003      
CZ-PrNML
005      
20200528094527.0
007      
ta
008      
200511s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/diagnostics10010033 $2 doi
035    __
$a (PubMed)31936486
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Melicherčík, Pavel $u Department of Orthopaedics, First Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Úvalu 84, 150 06 Prague 5, Czech Republic.
245    10
$a High-Performance Liquid Chromatography as a Novel Method for the Determination of α-Defensins in Synovial Fluid for Diagnosis of Orthopedic Infections / $c P. Melicherčík, E. Klapková, K. Kotaška, D. Jahoda, I. Landor, V. Čeřovský,
520    9_
$a The α-defensins (AD) present in synovial fluid have been regarded as constituting the most accurate periprosthetic joint infection (PJI) biomarker. The methods most commonly used for estimating AD as a biomarker are the qualitative Synovasure® PJI tests, based on the technique of lateral flow, and quantitative enzyme-linked immunosorbent assay (ELISA). Here, we propose a novel test based on detecting α-defensins in synovial fluid by high-performance liquid chromatography (HPLC). Synovial fluid was collected from 157 patients diagnosed with PJI, infectious arthritis (IA), arthrosis, reactive arthritis, and rheumatoid arthritis. AD concentrations in the fluid were determined by HPLC, and these same samples were used for additional diagnostic analyses. The results were statistically processed to calculate cutoff concentrations for PJI and IA. HPLC testing showed a sensitivity of 94% and a specificity of 92% for diagnosis of PJI, and a sensitivity of 97% and a specificity of 87% for diagnosis of IA. Using HPLC, we detected in synovial fluid a combination of three α-defensins: human neutrophil peptides HNP1, HNP2, and HNP3. All measured AD concentration values shown in this work refer to the sum of these three individual concentrations. Our study shows that the HPLC method meets the conditions for measuring precise concentrations of the sum of AD and can be recommended as part of a diagnostic array for PJI and IA diagnostics. By this method, we have verified that higher levels of AD in synovial fluid can also be seen in rheumatoid illnesses, crystal arthropathies, and reactive arthritis.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Klapková, Eva $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Úvalu 84, 150 06 Prague 5, Czech Republic.
700    1_
$a Kotaška, Karel $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Úvalu 84, 150 06 Prague 5, Czech Republic.
700    1_
$a Jahoda, David $u Department of Orthopaedics, First Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Úvalu 84, 150 06 Prague 5, Czech Republic.
700    1_
$a Landor, Ivan $u Department of Orthopaedics, First Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Úvalu 84, 150 06 Prague 5, Czech Republic.
700    1_
$a Čeřovský, Václav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
773    0_
$w MED00195450 $t Diagnostics (Basel, Switzerland) $x 2075-4418 $g Roč. 10, č. 1 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31936486 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200528094525 $b ABA008
999    __
$a ind $b bmc $g 1524305 $s 1095430
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 1 $e 20200109 $i 2075-4418 $m Diagnostics $n Diagnostics $x MED00195450
GRA    __
$a 16-27726A $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a RVO 61388963 $p Ústav Organické Chemie a Biochemie, Akademie Věd České Republiky
GRA    __
$a 9777 and 6010 $p Motol University Hospital
GRA    __
$a NV16-27726A $p MZ0
LZP    __
$a Pubmed-20200511

Find record

Citation metrics

Logged in users only

Archiving options